Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Shelley354on Jul 09, 2019 7:42pm

74 Views

Post# 29901566

RE:RE:PP misleading

Ticklel1st wrote: Well, Howie could have agreed to do the PP at .30. That would have been a disaster for shareholders.

I'm thinking a chinese director, Billings heasding up china negotiations and the equity position taken by china, we should be well on the way unlress you know who frucks it up.....and that is very possible.

I missed the news flash, no wonder the price fell this PM, leaked information, disgusting.

Bullboard Posts

Gold vs. bitcoin, where should you invest?